Differential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells.

Tamoxifen is the standard adjuvant endocrine therapy for estrogen-receptor positive premenopausal breast cancer patients. However, tamoxifen resistance is frequently observed under therapy. A tamoxifen resistant cell line has been generated from the estrogen receptor positive mamma carcinoma cell li...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Norbert Nass, Hans-Jürgen Brömme, Roland Hartig, Sevil Korkmaz, Saadettin Sel, Frank Hirche, Aoife Ward, Andreas Simm, Stefan Wiemann, Anne E Lykkesfeldt, Albert Roessner, Thomas Kalinski
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2014
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/ed2045353b0b4f2a9dcd740c593f972e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!